PDSB
Price
$0.29
Change
-$0.03 (-9.38%)
Updated
Sep 11 closing price
Capitalization
16.51M
61 days until earnings call
Intraday BUY SELL Signals
RNTX
Price
$0.79
Change
+$0.01 (+1.28%)
Updated
Sep 11 closing price
Capitalization
67.72M
62 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PDSB vs RNTX

PDSB vs RNTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
PDSB vs. RNTX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PDSB is a Hold and RNTX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNTX($67.7M) has a higher market cap than PDSB($16.5M). RNTX YTD gains are higher at: -32.328 vs. PDSB (-61.691). RNTX has higher annual earnings (EBITDA): -20.76M vs. PDSB (-26.99M). RNTX has more cash in the bank: 40.6M vs. PDSB (5.6M). PDSB (0) and RNTX (0) have equivalent revenues.
PDSBRNTXPDSB / RNTX
Capitalization16.5M67.7M24%
EBITDA-26.99M-20.76M130%
Gain YTD-61.691-32.328191%
P/E RatioN/AN/A-
Revenue00-
Total Cash5.6M40.6M14%
Total Debt4.36MN/A-
FUNDAMENTALS RATINGS
PDSB vs RNTX: Fundamental Ratings
PDSB
RNTX
OUTLOOK RATING
1..100
4738
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
42
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6578
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PDSB's Valuation (30) in the Pharmaceuticals Major industry is in the same range as RNTX (42) in the null industry. This means that PDSB’s stock grew similarly to RNTX’s over the last 12 months.

PDSB's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as RNTX (100) in the null industry. This means that PDSB’s stock grew similarly to RNTX’s over the last 12 months.

PDSB's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as RNTX (100) in the null industry. This means that PDSB’s stock grew similarly to RNTX’s over the last 12 months.

PDSB's Price Growth Rating (65) in the Pharmaceuticals Major industry is in the same range as RNTX (78) in the null industry. This means that PDSB’s stock grew similarly to RNTX’s over the last 12 months.

PDSB's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as RNTX (100) in the null industry. This means that PDSB’s stock grew similarly to RNTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PDSBRNTX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 5 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
Bullish Trend 9 days ago
78%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
86%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (PDSB: $0.29 vs. RNTX: $0.79)
Brand notoriety: PDSB and RNTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PDSB: 56% vs. RNTX: 66%
Market capitalization -- PDSB: $16.51M vs. RNTX: $67.72M
PDSB [@Biotechnology] is valued at $16.51M. RNTX’s [@Biotechnology] market capitalization is $67.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PDSB’s FA Score shows that 1 FA rating(s) are green while RNTX’s FA Score has 0 green FA rating(s).

  • PDSB’s FA Score: 1 green, 4 red.
  • RNTX’s FA Score: 0 green, 5 red.
According to our system of comparison, PDSB is a better buy in the long-term than RNTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PDSB’s TA Score shows that 5 TA indicator(s) are bullish while RNTX’s TA Score has 6 bullish TA indicator(s).

  • PDSB’s TA Score: 5 bullish, 3 bearish.
  • RNTX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, RNTX is a better buy in the short-term than PDSB.

Price Growth

PDSB (@Biotechnology) experienced а +34.05% price change this week, while RNTX (@Biotechnology) price change was -11.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

PDSB is expected to report earnings on Nov 12, 2026.

RNTX is expected to report earnings on Nov 13, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
PDSB
Daily Signal:
Gain/Loss:
RNTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLMT56.800.36
+0.64%
Calumet Inc.
SIGA3.030.01
+0.33%
SIGA Technologies
TRP60.88-1.03
-1.66%
TC Energy Corp
BRBR9.14-0.16
-1.72%
BellRing Brands
FGI8.31-0.15
-1.77%
FGI Industries Ltd

PDSB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDSB has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PDSB jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDSB
1D Price
Change %
PDSB100%
-6.47%
AXON - PDSB
43%
Loosely correlated
+0.10%
PRAX - PDSB
35%
Loosely correlated
-1.18%
VCYT - PDSB
35%
Loosely correlated
-2.76%
ARRY - PDSB
35%
Loosely correlated
+1.54%
ATNM - PDSB
34%
Loosely correlated
+6.87%
More

RNTX and

Correlation & Price change

A.I.dvisor tells us that RNTX and PRLD have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RNTX and PRLD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNTX
1D Price
Change %
RNTX100%
+0.53%
PRLD - RNTX
33%
Poorly correlated
-1.71%
CBIO - RNTX
27%
Poorly correlated
-0.26%
SMMT - RNTX
26%
Poorly correlated
+3.24%
PDSB - RNTX
25%
Poorly correlated
-6.47%
PRTA - RNTX
25%
Poorly correlated
-1.00%
More